Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.1K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.1K
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

426
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
426
Hazard Ratio01:12

Hazard Ratio

468
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
468
Odds Ratio01:09

Odds Ratio

1.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

321
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
321
Probability Laws01:49

Probability Laws

43.7K
Overview
43.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodology and quality assurance practices in performing anti-extractable nuclear antigen (ENA) analysis: an EFLM report on an international survey.

Clinical chemistry and laboratory medicine·2026
Same author

Autoantigen identification in antinuclear antibody-positive usual interstitial pneumonia without known autoantibody through immunoprecipitation-mass spectrometry.

ERJ open research·2026
Same author

Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritis.

RMD open·2026
Same author

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Journal of autoimmunity·2026
Same author

Prevalence of antisynthetase antibodies in a multicentre early rheumatoid arthritis cohort.

Acta clinica Belgica·2026
Same author

Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response.

Clinical immunology (Orlando, Fla.)·2025

Related Experiment Video

Updated: Dec 19, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

723

Likelihood Ratios as Value Proposition for Diagnostic Laboratory Tests.

Walter Fierz1, Xavier Bossuyt2,3

  • 1Schweizerischer Verband der Diagnostikindustrie (SVDI-ASID), Bern, Switzerland.

The Journal of Applied Laboratory Medicine
|June 6, 2020
PubMed
Summary
This summary is machine-generated.

Adding likelihood ratios to laboratory test results can improve diagnostic accuracy and demonstrate the economic value of clinical diagnostics. This data integration is crucial for healthcare reimbursement strategies.

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.0K

Related Experiment Videos

Last Updated: Dec 19, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

723
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.0K

Area of Science:

  • Clinical diagnostics
  • Health economics
  • Laboratory medicine

Background:

  • The clinical and economic value of laboratory diagnostics is under increasing debate.
  • Current methods for measuring diagnostic test effectiveness lack practical recommendations.
  • Subjective physician experience often dictates diagnostic significance, lacking objective measures.

Purpose of the Study:

  • To propose enriching laboratory test results with likelihood ratios for improved diagnostic effectiveness.
  • To highlight the potential of likelihood ratios in enhancing the impact and economic value of laboratory diagnostics.
  • To advocate for the inclusion of likelihood ratios in healthcare reimbursement strategies.

Main Methods:

  • Enriching laboratory test data with diagnostic likelihood ratios.
  • Objective assessment of diagnostic significance using likelihood ratios.
  • Evaluating the economic implications of providing likelihood ratios.

Main Results:

  • Likelihood ratios offer an objective measure of diagnostic significance, complementing physician experience.
  • Integrating likelihood ratios can demonstrably increase the impact and perceived value of laboratory diagnostics.
  • The provision of likelihood ratios has positive economic implications for healthcare.

Conclusions:

  • Likelihood ratios are essential for objectively measuring the effectiveness of diagnostic tests.
  • Incorporating likelihood ratios enhances the clinical and economic value of laboratory diagnostics.
  • Reimbursement strategies should consider likelihood ratios to reflect the true value of diagnostic tests.